- Home
- CTMX vs PGP Comparison
CTMX vs PGP Comparison
Compare CTMX & PGP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTMX
- PGP
- Stock Information
- Founded
- CTMX 2008
- PGP 2003
- Country
- CTMX United States
- PGP United States
- Employees
- CTMX N/A
- PGP N/A
- Industry
- CTMX Biotechnology: Pharmaceutical Preparations
- PGP Finance Companies
- Sector
- CTMX Health Care
- PGP Finance
- Exchange
- CTMX Nasdaq
- PGP Nasdaq
- Market Cap
- CTMX 444.3M
- PGP 82.7M
- IPO Year
- CTMX 2015
- PGP N/A
- Fundamental
- Price
- CTMX $2.36
- PGP $8.29
- Analyst Decision
- CTMX Strong Buy
- PGP
- Analyst Count
- CTMX 2
- PGP 0
- Target Price
- CTMX $5.00
- PGP N/A
- AVG Volume (30 Days)
- CTMX 2.7M
- PGP 39.8K
- Earning Date
- CTMX 08-07-2025
- PGP 01-01-0001
- Dividend Yield
- CTMX N/A
- PGP 10.84%
- EPS Growth
- CTMX 128.27
- PGP N/A
- EPS
- CTMX 0.49
- PGP N/A
- Revenue
- CTMX $147,557,000.00
- PGP N/A
- Revenue This Year
- CTMX N/A
- PGP N/A
- Revenue Next Year
- CTMX N/A
- PGP N/A
- P/E Ratio
- CTMX $4.86
- PGP N/A
- Revenue Growth
- CTMX 23.81
- PGP N/A
- 52 Week Low
- CTMX $0.40
- PGP $5.83
- 52 Week High
- CTMX $3.10
- PGP $7.81
- Technical
- Relative Strength Index (RSI)
- CTMX 53.34
- PGP 70.15
- Support Level
- CTMX $2.08
- PGP $7.92
- Resistance Level
- CTMX $2.44
- PGP $8.33
- Average True Range (ATR)
- CTMX 0.24
- PGP 0.08
- MACD
- CTMX -0.06
- PGP 0.02
- Stochastic Oscillator
- CTMX 27.94
- PGP 90.24
About CTMX CytomX Therapeutics Inc.
CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.
About PGP Pimco Global StocksPlus & Income Fund of Beneficial Interest
PIMCO Global Stocksplus & Income Fund is a closed-end management investment company. The objective of the fund is to seek a total return comprised of current income, current gains, and long-term capital appreciation. The fund invests a majority of the fund's net assets in a combination of securities and instruments that provide exposure to stocks and or produce income.